Biblio
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance. Drug Resist Updat. 2024;75:101098.
. Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production. J Nanobiotechnology. 2023;21(1):204.
. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy. Biomark Res. 2024;12(1):2.
.